The only Agentic AI, biomarker-driven heart failure system-of-care that is scalable to all patients in all care settings to materially improve patient outcomes.
Our differentiation is in capturing an accurate (absolute and direct) biomarker of worsening heart failure with a low cost, simple-to-use, non-invasive device. This approach is highly scalable across diverse healthcare settings and patient populations.
The lung fluid biomarker directly supports Guideline Directed Medical Therapy (GDMT) optimization and easily integrates into existing clinician workflows.
Lifewave’s CardioConnect™ system-of-care engages and empowers patients and their clinicians to proactively manage acute and chronic heart failure in home and remote settings.
Our AI-powered platform automates and distributes clinician workflows to optimize time and addresses clinician burnout.
The LifeWave heart failure solution will be evidence-based and supportive of value-based care through current economic frameworks and our SaaS business model.
Investigational Device. Limited United States Law to Investigational Use.
CardioConnect™ Platform Solution
- Agentic AI platform supporting Personalized Care & Supervised Self-Management
- Worsening Heart Failure Biomarker with Lung Fluid Measurement
- Non-Invasive Direct and Absolute Measure
- 15 sec. Capture over Clothing - BMI Agnostic
- Actionable and Algorithmic Therapeutic Guidance
- Supports Fluid Stabilization and GDMT Management
Medical Radar Technology
Leadership Team
LifeWave Biomedical is led by a team of proven executives across cardiology, digital health, operations, and medical technology. With deep expertise spanning patient care, product innovation, commercialization, and large-scale adoption, the team is united by a mission to transform heart failure management worldwide. A team of proven leaders uniting clinical, operational, and technology expertise to transform heart failure care.
Clinical
Advisors
LifeWave has engaged clinical heart failure leaders to inform our product strategy and clinical outcome studies.
Investors
LifeWave is currently raising a Series B Financing.
Health System Relationships
LifeWave is collaborating with leading value-based care healthcare systems.